Alan Fisher
CIK: 0002028654
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NEUP
Neuphoria Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Fisher Alan
Fisher Alan (SEC CIK 0002028654) files insider reports with the SEC as Director of Neuphoria Therapeutics Inc. (NEUP).
Signal8 holds 2 ownership filings by Fisher Alan, all Form 4s, filed between Apr 18, 2025 and Jan 21, 2026. Those filings report 2 transactions, from Apr 16, 2025 to Jan 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fisher Alan's filings is in BURLINGTON, MA.
Recent filings by Fisher Alan
Other insiders filing for Neuphoria Therapeutics Inc. (NEUP)
- Wilson David Ian, Director
- Davies Peter Miles Winston, Director
- Ryan Jane, Director
- Lynx1 Capital Management LP, 10% Owner
- Papapetropoulos Spyros, President and CEO